Mon Mar 13, 2023 – 5:09 pm EDTMon Mar 13, 2023 – 5:41 pm EDT
(LifeSiteNews) — The Norwegian Healthcare Investigation Board (NHIB) is the latest European body to announce that the so-called “affirmative model of care” for gender dysphoric minors is not supported by evidence and is advising against the use of cross-sex hormones, puberty blockers, and “sex change” surgeries for minors. The NHIB recommended that these “treatments” be classified as experimental and noted that the spike in children identifying as transgender is concerning.
“The knowledge base, especially research-based knowledge, for gender confirmation treatment (hormonal and surgical) is insufficient,” the report notes. “Little is known about the long-term effects.” Instead, the NHIB recommends that more data — especially follow-up data — be collected and noted that the current standards endanger children, who cannot consent to the irreversible impacts of these treatments. Media reports indicate that the new recommendations come after families complained about “safety, lack of parental involvement, and lack of follow up for underage patients.”
READ: Tennessee governor signs laws banning drag queen shows and ‘gender transitions’ for children
In the United States, legislatures passing laws restricting the use of the “affirmative model” are
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
